GlassScriptPhysician profile
John P Simmons
NPI 1841285962
$631.69
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $192 · 2020: $69.57 · 2021: $50.51 · 2022: $87.68 · 2023: $115 · 2024: $117.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $165 · Education: $67.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $165.15 |
| Education | $67.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Jazz Pharmaceuticals INC. | $154.38 | 2019-2023 | Xywav |
| Harmony Biosciences LLC | $116.27 | 2022-2024 | Wakix |
| Novartis Pharmaceuticals Corporation | $101.12 | 2019 | |
| Pfizer INC. | $90.42 | 2024 | |
| Lilly USA, LLC | $49.58 | 2019-2020 | |
| Medtronic USA, INC. | $21.91 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $19.42 | 2020 | |
| Acorda Therapeutics, INC | $17.94 | 2019 | |
| Emd Serono, INC. | $17.39 | 2020 | |
| Biogen, INC. | $15.35 | 2021 | |
| Axsome Therapeutics, INC. | $14.74 | 2023 | Sunosi |
| Neurocrine Biosciences, INC. | $13.17 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Simmons listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.